Vildagliptin
Vildagliptin
Vildagliptin (pronounced vil-dag-lipt-in) is a pharmaceutical drug used in the treatment of Type 2 diabetes. It is classified under the drug class known as Dipeptidyl peptidase-4 inhibitors or DPP-4 inhibitors.
Etymology
The name 'Vildagliptin' is derived from the systematic IUPAC name (International Union of Pure and Applied Chemistry) which is (S)-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carboxylic acid. The 'Vil' in Vildagliptin is an arbitrary prefix used in pharmaceutical nomenclature, while 'gliptin' is a common stem used for DPP-4 inhibitors.
Usage
Vildagliptin is used in conjunction with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It works by increasing the amount of insulin produced by the body and decreasing the amount of sugar made by the body.
Related Terms
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- Dipeptidyl peptidase-4 inhibitors: A class of oral hypoglycemics that block DPP-4. They can be used to treat diabetes mellitus type 2.
- Insulin: A hormone that regulates the amount of glucose in the blood.
- Glucose: A simple sugar that is an important energy source in living organisms and is a component of many carbohydrates.
Side Effects
Common side effects of Vildagliptin include headache, dizziness, and flu-like symptoms such as runny nose and sore throat. In rare cases, it can cause pancreatitis.
See Also
- Metformin: Another medication used to treat type 2 diabetes.
- Sulfonylurea: A class of medications used to treat type 2 diabetes.
External links
- Medical encyclopedia article on Vildagliptin
- Wikipedia's article - Vildagliptin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski